Omniscope

Omniscope was founded in 2020 in response to the global pandemic by a group of scientists who wanted to be of service to humanity at a critical moment for our species. Together, we seek to apply our expertise for immediate impact.

We observed that “modern” medicine was using diagnostic tools that tend to be too narrowly focused - looking only at one disease at a time or focused on specific DNA sequence variations - resulting in diagnostic journeys of time-consuming guesswork. Frustrated that many groundbreaking scientific discoveries stayed in the scientific community instead of helping patients, we were called to find ways to put science in service of humanity and ensure cutting-edge science was accessible to all.

What emerged from these passionate conversations was a universal diagnostic to detect diseases broadly and bring our humanistic vision of health equity to life.

Our technology is a universal diagnostic tool that scans the immune system through simple, non-invasive clinical tests to broadly detect diseases at the earliest stages. We believe it will truly revolutionize today’s “modern” medicine to be more precise, personalized, and pragmatic, making our healthcare systems more resilient.